ELISA
New Biomarker, Test From Wash U Team Aims to ID Patients at Higher Risk of Cardiovascular Disease
Premium
The diagnostic blood test for elevated serum fatty acid synthase detected patients at risk of chronic limb-threatening ischemia with 83 percent accuracy.
A new digital and microfluidic ELISA technique optimized for bedside diagnostics offers high sensitivity at low cost with fast turnaround times.
Zeus Scientific Gets FDA Emergency Use Authorization for SARS-CoV-2 Total Antibody Test
Late last year, the company received Emergency Use Authorization from the FDA for a test that detects IgG antibodies against SARS-CoV-2.
Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications. Â
After nearly a year in development, the firm's rapid antigen test will be submitted by the end of March for a prescription-use claim.
Feb 19, 2021
Feb 11, 2021
Eurofins Gets CE Mark for Coronavirus Antibody Test
Feb 10, 2021
VolitionRx Prices $20M Public Offering
Jan 4, 2021
Oct 28, 2020
Biodesix Prices $72M IPO
Oct 23, 2020
FDA Approves Avioq's Supplemental HIV Test
May 20, 2020